ATRX expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.77191594730175E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.03389996564118E-09 |
Normal-vs-Stage2 |
1.397720E-04 |
Normal-vs-Stage3 |
5.12145881259585E-13 |
Normal-vs-Stage4 |
1.7972290322632E-12 |
Stage1-vs-Stage2 |
8.574400E-01 |
Stage1-vs-Stage3 |
4.716800E-03 |
Stage1-vs-Stage4 |
1.095490E-03 |
Stage2-vs-Stage3 |
1.767430E-01 |
Stage2-vs-Stage4 |
1.068420E-01 |
Stage3-vs-Stage4 |
6.716000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.26347845916553E-12 |
Normal-vs-AfricanAmerican |
4.62130334000221E-11 |
Normal-vs-Asian |
7.946000E-02 |
Caucasian-vs-AfricanAmerican |
3.460300E-02 |
Caucasian-vs-Asian |
4.916600E-01 |
AfricanAmerican-vs-Asian |
1.126600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.07036601804111E-12 |
Normal-vs-Female |
9.56800194629182E-11 |
Male-vs-Female |
4.783200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.50163999999009E-05 |
Normal-vs-Age(41-60Yrs) |
1.37590000504062E-08 |
Normal-vs-Age(61-80Yrs) |
1.64102065269844E-12 |
Normal-vs-Age(81-100Yrs) |
2.55090000012004E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.819200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.438600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.889800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.398300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.848300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.264800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.578160E-01 |
Normal-vs-Grade 2 |
9.26130000022951E-07 |
Normal-vs-Grade 3 |
7.95807864051312E-13 |
Normal-vs-Grade 4 |
1.64568358940187E-12 |
Grade 1-vs-Grade 2 |
2.832600E-01 |
Grade 1-vs-Grade 3 |
3.061100E-03 |
Grade 1-vs-Grade 4 |
5.578400E-04 |
Grade 2-vs-Grade 3 |
1.459180E-03 |
Grade 2-vs-Grade 4 |
5.62579999999757E-05 |
Grade 3-vs-Grade 4 |
6.587800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.81050000003236E-06 |
Normal-vs-ccB subtype |
4.92639262716921E-12 |
ccA subtype-vs-ccB subtype |
5.255200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.72009970103682E-10 |
Normal-vs-N1 |
4.1045999999989E-05 |
N0-vs-N1 |
3.288400E-01 |
|
|